Literature DB >> 14684627

Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.

Ceres C Chua1, Nader Rahimi, Kimberly Forsten-Williams, Matthew A Nugent.   

Abstract

Fibroblast growth factor-2 (FGF2) activates the extracellular signal-regulated kinases 1 and 2 (ERK1/2) through its specific receptors. Interaction of FGF2 with cell-surface heparan sulfate proteoglycans has also been suggested to induce intracellular signals. Thus, we investigated whether FGF2 can stimulate ERK1/2 activation through heparan sulfate proteoglycans using mechanisms that do not depend on receptor activation in vascular smooth muscle cells. The activation of FGF receptors was inhibited by treating cells with 5'-deoxy-5'methyl-thioadenosine and by expressing truncated dominant-negative FGF receptors. In both cases, FGF2 was able to stimulate the phosphorylation of ERK1/2 despite the absence of detectable FGF receptor tyrosine kinase activity. The FGF2 activation of ERK1/2 in the absence of receptor activity was completely dependent on heparan sulfate, because this activity was abolished by heparinase III digestion of the cells. In contrast, heparinase III treatment of control cells, with functional FGF receptors, showed only slight changes in FGF2-mediated ERK1/2 activation kinetics. Thus, in addition to serving as coreceptors for FGF receptor activation, heparan sulfate proteoglycans might also function directly as receptors for FGF2-induced ERK1/2 activation. Activation of ERK1/2 via cell-surface proteoglycans could have significant biological consequences, potentially directing cell response toward growth, migration, or differentiation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14684627     DOI: 10.1161/01.RES.0000112965.70691.AC

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  37 in total

1.  Heparin treatment of vascular smooth muscle cells results in the synthesis of the dual-specificity phosphatase MKP-1.

Authors:  Cheryl Isleib Blaukovitch; Raymond Pugh; Albert C Gilotti; Daniela Kanyi; Linda J Lowe-Krentz
Journal:  J Cell Biochem       Date:  2010-05-15       Impact factor: 4.429

2.  Syndecan-4 proteoliposomes enhance fibroblast growth factor-2 (FGF-2)-induced proliferation, migration, and neovascularization of ischemic muscle.

Authors:  Eugene Jang; Hassan Albadawi; Michael T Watkins; Elazer R Edelman; Aaron B Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

3.  The TCF4/β-catenin pathway and chromatin structure cooperate to regulate D-glucuronyl C5-epimerase expression in breast cancer.

Authors:  Luydmila A Mostovich; Tatiana Y Prudnikova; Aleksandr G Kondratov; Natalya V Gubanova; Olga A Kharchenko; Olesya S Kutsenko; Pavel V Vavilov; Klas Haraldson; Vladimir I Kashuba; Ingemar Ernberg; Eugene R Zabarovsky; Elvira V Grigorieva
Journal:  Epigenetics       Date:  2012-07-18       Impact factor: 4.528

4.  Heparin mimicking polymer promotes myogenic differentiation of muscle progenitor cells.

Authors:  Nivedita Sangaj; Phillip Kyriakakis; Darren Yang; Chien-Wen Chang; Gaurav Arya; Shyni Varghese
Journal:  Biomacromolecules       Date:  2010-11-08       Impact factor: 6.988

Review 5.  Heparanase and hepatocellular carcinoma: promoter or inhibitor?

Authors:  Shuo Dong; Xiong-Zhi Wu
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

6.  PDGF-A interactions with fibronectin reveal a critical role for heparan sulfate in directed cell migration during Xenopus gastrulation.

Authors:  Erin M Smith; Maria Mitsi; Matthew A Nugent; Karen Symes
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

7.  The syndecan-4/protein kinase Cα pathway mediates prostaglandin E2-induced extracellular regulated kinase (ERK) activation in endothelial cells and angiogenesis in vivo.

Authors:  Federico Corti; Federica Finetti; Marina Ziche; Michael Simons
Journal:  J Biol Chem       Date:  2013-03-22       Impact factor: 5.157

8.  Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling.

Authors:  A H Palamakumbura; S R Vora; M A Nugent; K H Kirsch; G E Sonenshein; P C Trackman
Journal:  Oncogene       Date:  2009-07-13       Impact factor: 9.867

9.  A computational model of FGF-2 binding and HSPG regulation under flow.

Authors:  Wensheng Shen; Changjiang Zhang; Michael W Fannon; Kimberly Forsten-Williams; Jun Zhang
Journal:  IEEE Trans Biomed Eng       Date:  2008-07-15       Impact factor: 4.538

10.  A novel fragment derived from the beta chain of human fibrinogen, beta43-63, is a potent inhibitor of activated endothelial cells in vitro and in vivo.

Authors:  E Krajewska; C E Lewis; Y-Y Chen; A Welford; S Tazzyman; C A Staton
Journal:  Br J Cancer       Date:  2010-01-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.